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Abstract: The plant family Amaryllidaceae is well-known for its unique alkaloid constituents,
which exhibit a wide range of biological activities. Its representative, Amaryllis belladonna, has a
geographical distribution covering mainly southern Africa, where it has significant usage in the
traditional medicine of the native people. In this study, A. belladonna samples collected in Brazil
were examined for alkaloid content. Alkaloid profiles of A. belladonna bulbs were generated by
a combination of chromatographic, spectroscopic and spectrometric methods, including GC–MS
and 2D NMR. In vitro screening against four different parasitic protozoa (Trypanosoma cruzi,
T. brucei rhodesiense, Leishmania donovani and Plasmodium falciparum) was carried out using the
A. belladonna crude methanol extract, as well as three of its alkaloid isolates. Twenty-six different
Amaryllidaceae alkaloids were identified in the A. belladonna bulb samples, and three of them were
isolated. Evidence for their respective biosynthetic pathways was afforded via their mass-spectral
fragmentation data. Improved data for 1-O-acetylcaranine was provided by 2D NMR experiments,
together with new 1H-NMR data for buphanamine. The crude extract and 3-O-acetylhamayne
exhibited good antiprotozoal activity in vitro, although both with a high cytotoxic index.
Keywords: Amaryllis belladonna; Amaryllidaceae; alkaloids; biosynthetic pathways; NMR; MS
1. Introduction
The plant family Amaryllidaceae has attracted considerable attention in view of the fascinating
structural features and varied biological activities manifested by its alkaloid principles. Anticancer,
antimicrobial and anticholinesterase activities represent some of these biological properties [1].
The genus Amaryllis L. comprises two species, A. belladonna and A. acuminata, both native to southern
Africa [2]. Also referred to by the folk names “belladonna-lily” and “naked-lady”, A. belladonna has
been used for several centuries in the medicinal traditions of the Sotho, Xhosa and Zulu peoples of
South Africa, and in Java for the treatment of “swelling” (a presumed synonym for cancer) [2,3].
The characteristic isoquinoline alkaloids produced by members of the Amaryllidaceae are
derived from the aromatic amino acids phenylalanine and tyrosine, which combine to give the
common precursor O-methylnorbelladine [4]. Consequently, alternative ways of oxidative phenolic
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coupling of this key intermediate metabolite lead to the three main discernible skeleton types that
form the basis for further structural diversity in the Amaryllidaceae. The ortho–para´ coupling of
O-methylnorbelladine results in the formation of the lycorine-type skeleton, which in turn leads
to homolycorine-type compounds. The galanthamine-type skeleton originates from para–ortho´
phenolic oxidative coupling, whilst para–para´ coupling gives the crinine-, haemanthamine-, tazettine-,
narciclasine- and montanine-type structures [5].
Gas chromatography-mass spectrometry (GC–MS) studies of Amaryllidaceae plants show
that they contain a quite variable number of alkaloids [6,7]. Each species produces a mixture of
alkaloids, often with a few dominant compounds and a larger number of compounds at lower
concentrations, which is likely to result from differences in substrate specificity and expression level of
the various biosynthetic enzymes [8]. The evolution of the biosynthetic pathways in the production of
Amaryllidaceae alkaloids remains unclear [9]. Most research on Amaryllidaceae alkaloid biosynthesis
was carried out during the 1960s and early 1970s. More recently, there has been notable interest in the
biosynthesis of galanthamine and its congeners, given their success as commercial drug targets [10].
In this regard, in 2001, galanthamine was approved by the FDA (Food and Drug Administration) for
the clinical management of mild to moderate Alzheimer’s disease [11]. Subsequently, there has been
widespread interest in the Amaryllidaceae as a source of novel chemotherapeutics [12].
Thirty-one alkaloids have been previously identified in A. belladonna, including 1-O-acetylcaranine,
6-hydroxybuphanisine, 6-hydroxycrinine, 8-demethylmaritidine, 11-hydroxyvittatine, amarbellisine,
amaryllidine, amaryllisine, ambelline, anhydrolycorinone, anhydrolycorinium, belladine, bellamarine,
buphanamine, caranine, crinine, galanthamine, galanthine, hippadine, hippeastrine, ismine, lycorenine,
lycorine, pancracine, parkacine, parkamine, powelline, pratorimine, pratosine, undulatine and
vittatine [2,13–21]. Anti-bacterial, anti-fungal and anti-neoplastic effects are associated with some of
the alkaloids isolated from A. belladonna [2,20].
Protozoal diseases such as leishmaniasis, trypanosomiasis and malaria are still the most prevalent
parasitic diseases worldwide, with a significant social and economic impact [22]. In many cases,
contemporary chemotherapeutic regimens are not satisfactory due to a lack of effectiveness as well as
the toxicity associated with long-term treatment. Furthermore, the emergence of global drug resistance
has necessitated the development of new anti-parasitological drugs [23,24].
The aim of this work was to perform a detailed study of the alkaloid constituents of A. belladonna
utilizing spectroscopic and chromatographic methods, including GC–MS and NMR. In this way,
twenty-six alkaloids were identified and evidence presented for their respective biosynthetic pathways.
Furthermore, a comprehensive NMR study of 1-O-acetylcaranine is presented, together with new
1H-NMR data of buphanamine. Finally, anti-parasitological activities of the crude extract and three
isolated alkaloids from A. belladonna are reported for the first time.
2. Results and Discussion
2.1. Alkaloids Identified in A. belladonna by GC–MS
The structural types of the alkaloids from A. belladonna were identified by comparing their GC–MS
spectra and Kovats retention index (RI) values with those of authentic Amaryllidaceae alkaloids
previously isolated and identified by spectrometric methods as nuclear magnetic resonance (NMR),
ultraviolet (UV), circular dichroism (CD) and mass spectrometry (MS) in our laboratory. The NIST 05
Database and literature data were also used (Table 1). The MS spectra were deconvoluted by AMDIS
2.64 software (NIST).
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Table 1. Alkaloids identified in A. belladonna by GC–MS.
Alkaloid RI M+ MS
ismine (1) 2288.1 257 (28) 239 (20), 238 (100), 225 (7), 211 (7), 196 (9), 180 (8), 139 (8)
trisphaeridine (2) 2305.0 223 (100) 224 (15), 222 (38), 193 (2), 164 (15), 138 (26), 111 (14)
buphanisine (3) 2447.5 285 (100) 270 (34), 254 (34), 242 (12), 227 (24), 215 (85), 201 (23), 185 (22), 172 (22), 157 (33), 128 (33)
anhydrolycorine (4) 2470.2 251 (42) 250 (100), 220 (3), 192 (18), 163 (3), 125 (2)
caranine (5) 2560.9 271 (59) 270 (37), 252 (53), 240 (10), 227 (44), 226 (100), 212 (6), 181 (1)
1-O-acetylcaranine (6) 2569.6 313 (72) 270 (3), 252 (100), 240 (9), 227 (41), 226 (97)181 (2)
8-O-demethylmaritidine (7) 2575.5 273 (100) 256 (13), 244 (12), 230 (26), 216 (14), 201 (90), 189 (61), 175 (28), , 157 (19), 141 (11), 128 (24)
vittatine (8) 2578.0 271 (100) 254 (11), 242 (11), 228 (22), 214 (13), 199 (58), 187 (63), 173 (24), 157 (18), 141(13), 128 (29)
O-methylnorbelladine (9) 2578.5 273 (-) 166 (36), 137 (100), 122 (8), 94 (6)
11,12-dehydroanhydrolycorine (10) 2638.1 249 (59) 248 (100), 218 (1),190 (26), 163 (8), 137 (1), 123 (5), 95 (13)
6-methoxylbuphanidrine (11) 2656.8 345 (58) 330 (33), 298 (14), 287 (32), 259 (68), 227 (30), 181 (10), 145 (13)
3-O-acetylvittatine (12) 2690.6 313 (100) 298 (1), 284 (6), 270 (27), 254 (75), 252 (61), 224 (38), 216 (60), 198 (36), 187 (36), 139 (15), 128 (33)
powelline (13) 2702.7 301 (100) 284 (10), 272 (14), 258 (39), 244 (24), 229 (8), 217 (7), 202 (22), 187 (23), 159 (13), 143 (11), 127 (19)
buphanidrine (14) 2705.2 315 (100) 300 (31), 284 (35), 272 (9), 260 (39), 245 (69), 228 (24), 215 (21), 202 (20), 187 (18), 130 (18)
lycorine (15) 2722.0 287 (18) 286 (10), 268 (19), 250 (16), 238 (7), 227 (78), 226 (100), 211 (6), 147 (5), 119 (3)
buphanamine (16) 2726.5 301 (100) 282 (21), 272 (13), 256 (22), 244 (11), 190 (7), 165 (9)
1-O-acetyllycorine (17) 2754.9 329 (31) 268 (31), 250 (20), 227 (64), 226 (100), 211 (6), 192 (3), 167 (3), 147 (6)
3-O-acetylpowelline (18) 2768.7 343 (100) 314 (6), 300 (25), 284 (78), 283 (24), 268 (9), 254 (21), 246 (81), 228 (39), 217 (18), 202 (6), 183 (9)
hippadine (19) 2775.0 263 (100) 233 (2), 205 (7), 177 (24), 150 (13), 131 (9), 111 (2), 75 (7)
ambelline (20) 2814.6 331 (86) 316 (8), 299 (44), 287 (100), 270 (33), 260 (76), 257 (58), 239 (52), 228 (20), 211 (62), 190 (39)
6-hydroxybuphanidrine (21) 2828.4 331 (44) 314 (5), 300 (10), 282 (7), 276 (100), 261 (33), 258 (13), 243 (12), 228 (8), 217 (21), 216 (22)
11-O-acetylambelline (22) 2850.2 373 (100) 314 (58), 313 (50), 282 (46), 258 (48), 255 (36), 254 (63), 241 (38), 240 (35), 218 (44)
undulatine (23) 2855.2 331 (100) 316 (9), 300 (9), 286 (15), 258 (33), 244 (14), 232 (17), 217 (28), 205 (60), 189 (32), 173 (30)
3-O-acetylhamayne (24) 2907.7 329 (3) 300 (100), 269 (6), 240 (16), 224 (8), 212 (34), 211 (14), 199 (6), 181 (54), 167 (3), 153 (18), 128 (10)
crinamidine (25) 2954.3 317 (59) 300 (2), 288 (100), 258 (21), 244 (27), 230 (16), 217 (35), 203 (34), 189 (20), 173 (40), 145 (17)
distichamine (26) 2984.3 329 (100) 328 (25), 314 (15), 300 (9), 286 (9), 269 (5), 256 (3), 231 (20), 204 (13), 190 (5), 130 (2)
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Fourteen of the identified alkaloids were detected for the first time in this species: trisphaeridine [2],
buphanisine [3], anhydrolycorine [4], 11,12-dehydroanhydrolycorine [10], 6-methoxybuphanidrine [11],
3-O-acetylvittatine [12], buphanidrine [14], 1-O-acetyllycorine [17], 3-O-acetylpowelline [18],
6-hydroxybuphanidrine [21], 11-O-acetylambelline [22], 3-O-acetylhamayne [24], crinamidine [25] and
distichamine [26]. All the alkaloids found in A. belladonna belong to the typical Amaryllidaceae alkaloid
groups, including the lycorine, crinine and haemanthamine groups. 1-O-Acetylcaranine [6] was the most
abundant alkaloid and the crinine group was the most represented, whilst no galanthamine-type alkaloids
were detected in this plant.
Based on their structural identities, it has been possible to show how the alkaloids identified in
A. belladonna could be linked biosynthetically (Figure 1). We propose that the chemical similarity of
the alkaloid types from this species may be due to different combinations of common biosynthetic
reactions, such as hydroxylation, hydrogenation, reduction, epoxidation, methylation, methoxylation,
acetylation and allylic rearrangements, starting from a common precursor. Precedence for these
reactions has been studied in other alkaloid groups; for example, indole alkaloids in Catharanthus
roseus (Apocynaceae) [26,27].
To date, galanthamine metabolization represents the most studied Amaryllidaceae alkaloid
biosynthetic pathway. Experiments involving the application of 13C-labelled O-methylnorbelladine
to field-grown Leucojum aestivum plants indicate that galanthamine biosynthesis involves phenolic
oxidative coupling of O-methylnorbelladine to a dienone, the adduct of which undergoes spontaneous
conversion to N-demethylnarwedine. The latter is converted via stereoselective reduction to
N-demethylgalanthamine, which is then N-methylated to galanthamine [10].
Benzylamine O-methylnorbelladine (9) was also shown to be a precursor of norpluviine (27),
which is known to be integral to lycorine-type alkaloid metabolization [28]. Apart from this,
the transformation of caranine (5) into lycorine (15) has been observed in both Zephyranthes candida
and Clivia miniata [29,30]. In A. belladonna, it is conceivable that 1-O-acetylcaranine (6) and
1-O-acetyllycorine (17) are derived via acetylation of the C-1 hydroxy group in caranine (5) and lycorine
(15), respectively. Furthermore, we suggest that lycorine (15) could be metabolized to anhydrolycorine
(4) by double dehydration of the C-1 and C-2. Also, we suggest that anhydrolycorine (4) may be a
precursor of 11,12-dehydroanhydrolycorine (10) by reduction of the D-ring double bond, which could
then serve as a precursor to hippadine (19) via hydroxylation at C-6 and subsequent oxidation to the
amide functionality.
Crinine (31) can be considered the precursor of all crinine-type alkaloids in possession of
the methylenedioxy group, whilst buphanisine (3) and powelline (13) may be easily derived from
crinine (31) by methylation and methoxylation reactions at C-3 and C-7, respectively. In addition,
C-7 methoxylation of buphanisine (3) and/or C-3 methylation of powelline (13) are possible
alternative steps in the buphanidrine (14) biosynthetic pathway. The presence of ambelline (20) and
11-acetylambelline (22) suggests a C-11 hydroxylation of buphanidrine (14) followed by an acetylation
reaction. Buphanidrine (14) is a likely precursor of 6-hydroxybuphanidrine (21), which could then lead
to 6-methoxybuphanidrine (11) via a methylation reaction. Also in the crinine group, it is conceivable
that metabolic acetylation of powelline (13) would afford 3-O-acetylpowelline (18). Powelline (13) could
also facilitate crinamidine (25) metabolization via C-2, C-3 epoxidation. This would subsequently lead
to undulatine (23) by C-3 methylation, which in turn is distinguished as the precursor to distichamine
(26) following allylic rearrangement. Further to this, 8-O-demethylmaritidine (7) is a plausible
precursor of vittatine (8) via methylenedioxy group transformation, from which 3-O-acetylvittatine
(12) may be readily accessible. The presence of 3-O-acetylhamayne (24) suggests that the structurally
related alkaloids siculine (28), epivittatine (29) and hamayne (30) may also be present, but in hitherto
undetectable quantities in A. belladonna.
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this plant but which could be involved in the metabolic route include norpluviine (27), siculine (28),
epivittatine (29), hamayne (30) and crinine (31).
2.2. 1-O-Acetylcaranine
The base ion signal that occurs at m/z 252 in 1-O-acetylcaranine (6) is characteristic of deacetylation
at C-1 and dehydration at C-1 and C-2 (Figure 2). Herein we present the complete NMR data
for 1-O-acetylcaranine (6) by both 1D and 2D NMR spectroscopic analysis (see 1-O-acetylcaranine
NMR spectra in Supplementary Materials). The 1H-NMR spectrum (Table 2) was similar to that of
1-O-acetylcaranine and caranine [13,31,32]. The shift of the H-1 proton signal to a lower magnetic field
than that observed for caranine suggested a substitution of the hydroxyl group at C-1, which was further
substantiated by the presence of a singlet at δ 1.93, indicative of an acetyl group. The 13C-NMR spectrum
showed a singlet resonance signal at δ 171.0, which confirmed the presence of one carbonyl group.
The COSY spectrum showed an allylic coupling between H-3 and H-4a and between H-3 and H-11,
which allowed us to determine the H-10b proton location in the 1H-NMR spectrum. In addition, the small
magnitude of the coupling constants between H-1 and H-10b allowed us to assign the α-orientation to
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the acetyl group. The two C-6 protons were differentiated as an AB system with a geminal coupling
of around 14 Hz. H-4a showed NOESY correlations with both H-2α and H-6α, which turned out to
be key correlations in the assignment of their orientation. Furthermore, H-12α was ascribable to a
higher field as a consequence of NOESY contour correlation with H-6α. The HMBC spectrum allowed
us to assign the quaternary carbons C-6a (δ 129.5) and C-10a (δ 127.8) via three-bond correlation with
H-10 and H-7, respectively. The aromatic protons were ascribable to H-7 and H-10 due to three-bond
HMBC correlations with C-10a and C-6a, respectively, in addition to NOESY correlations observed for
the H-6/H-7 and H-1/H-10 proton pairs. The C-8 quaternary carbon (δ 146.2) was located via four-bond
HMBC connectivity with both H-6, as well as via three-bond connectivity with H-10. The quaternary
carbon C-9 (δ 146.5) was determined via three-bond HMBC connectivity with H-7. Finally, the singlet
resonance signal at δ 139.26 was assigned to C-4, taking into account three bond connectivities to H-12β.
All these data are in agreement with the structure of 1-O-acetylcaranine (6) (see Figure 4).
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Position δC, Type δH (J in Hz) HMBC
1 66.60 d 5.84 br dd (4.5, 2.0) C-3, C-4a, C-10b, OCOCH3
2α 33.55 t 2.39 m
2β 33.55 t 2.64 m
3 114.43 d 5.39 dd (4.9, 2.4) C-4a, C-1
4 139.56 s
4a 61.51 d 2.82 d (10.8)
6α 57.09 t 3.54 d (14.3) C-10a
6β 57.09 t 4.13 d (14.1) C-4a, C-7, C-10a
6a 129.54 s
7 107.34 d 6.57 br s C-6, C-9, C10a
8 146.24 s
9 146.49 s
10 105.25 d 6.72 d (1.0) C-6a, C-8, C-10b
10a 127.79 s
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11β 28.70 t 2.61 m
12α 53.83 t 2.39 m C-6
12β 53.83 t 3.33 ddd (9.4, 4.9, 4.4) C-4, C-4a, C-6
OCH2O 101.16 t 5.91 d (1.5)–5.92 d (1.5)
OCOCH3 171.03 q 1.93 s
OCOCH3 21.53 q 1.93 s
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2.3. Buphanamine
For most crinine-type alkaloids, the molecular ion is prominent as the base peak, and the
fragmentation mechanism is initiated by opening of the C-11/C-12 ethano-bridge, indicating bond
cleavage at the position β to the nitrogen atom (Figure 3) [33].Molecules 2017, 22, 1437 7 of 12 
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The 1H-NMR data we obtained for buphanamine (16) (Table 3) differed slightly from the
data available in the literature [34]. The discrepancies we noted relate to the H-4α, H-4β, H-4a,
H-6α, H-6β, H-11endo, H-1 exo, H-12 ndo and H-12exo proton resonanc s (∆ +0.26, +0.22, +0.36,
+0.26, +0.27, +0.14, +0.20, +0.24, +0.51, respectively). The e ar q ite dow field-shifted compared
to the corresponding data we obtained in our NMR analysis (see buphanamine NMR spectra in
Supplementary Materials). Quaternization of the nitrogen atom via N-oxide or salt formation is known
to influence the chemical shifts of protons in its vicinity [1].
Table 3. 13C-NMR, 1H-NMR and HMBC data of buphanamine (16) (500 MHz, CDCl3).
Position δC, Type δH (J in Hz) HMBC
1 64.5 d 4.74 d (5.5) C-3, C-4a, C-10a, C-11
2 125.5 d 6.00 ddd (10.0, 5.5, 2.8, 1.8) C-10b
3 128.9 d 5.86 ddd (10.0, 4.5, 2.8) C-4a
4α 28.2 t 2.57 dddd (19.7, 8.1, 4.5, 1.9) C-2, C-10b
4β 28.2 t 1.99 dddd (19.8, 8.6, 1.1, 0.3) C-2, C-10b
4a 59.2 d 3.43 t (8.3) -10a
6a 117.9 s
6α 56.9 t 4.17 d (17.2) C-4a, C-7, C-10a
6β 56.9 t 3.81 d (17.2) C-4a, C-7, C-10a
7 140.8 s
8 133.6 s
9 148.6 s
0 98.0 d 6 59 s C-6a, C-8, C-10b
10a 13 .0 s
10b 48.3 s
11endo 38.7 t 1.85 ddd (11.9, 8 8, 3.1, 1.3) 4a, C-10a
11exo 38.7 t 1.92 ddd (12.1, 10.0, 7.3) C-4a, C-10a
12endo 5 .4 t 2.75 ddd (13.0, 8.8, 7.2) C-4a, C-6
12exo 51.4 t 3.40 ddd (13.0, 10.0, 3.0) C-6, C-10b
OCH2O 100.7 t 5.88 d (1.5)–5.89 d (1.5) C-8, C-9
OCH3 59.1 q 3.98 s C-7
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In the 1H-NMR spectrum, the coupling constants between H-1 and H-2 (J = 5.5 Hz), H-2 and H-3
(J = 10.0 Hz), H-3 and H-4α (J = 4.5 Hz), together with the geminal coupling of around 19.7 Hz between
H-4α and H-4β, allowed us to place the hydroxyl group at C-1 and the double bond between C-2 and
C-3. The NOE contour between H-1 and 2H-11, and the homoallylic coupling between H-1 and H-4β,
confirmed the α-orientation for the hydroxyl group. Interestingly, the COSY correlation observed
between H-2 and 2H-4 also confirmed the allylic coupling between these protons. The two H-6 protons
were clearly differentiated as part of an AB system, each with a geminal coupling value of 17.2 Hz.
The singlet aromatic proton resonance was ascribable to H-10 due to three-bond HMBC correlations
with C-6a and C-10b, in addition to a NOESY correlation with H-1, allowing the aromatic methoxyl
group to be placed at C-7. H-6αwas assigned to a lower field via a NOESY contour correlation with
H-4a (Figure 4). The H-11exo and H-12exo protons were assignable based on the large values of their
respective coupling constants. The quaternary carbons C-6a and C-10a were ascribed by means of their
three-bond HMBC correlations with H-10 and H-1, respectively. Finally, the singlet resonance signal at
δ = 48.3 was assigned to C-10b, taking into account three-bond connectivities to H-10, H-4α and H-4β.
The absolute configuration of this alkaloid was determined from the CD spectrum, wherein the curve
was qualitatively similar to that of buphanamine (16) [35].
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Table 4. In vitro antiprotozoal and cytotoxic activities of A. belladonna.
Parasite T. b. rhodesiense T. cruzi L. donovani P. falciparum Cytotoxicity
Stage Trypamastigotes Amastigotes Amastigotes IEF(Intraerythrocytic)
Strain STIB 900 (IC50 a)
Tulahuen C4 LacZ
(IC50 a)
MHOM-ET-67/L82
(IC50 a)
NF54 (IC50 a) L6 (IC50 a)
melarsoprol 0.0035 b and 0.0010 c
benznidazole 0.660 b and 1.080 c
miltefosine 0.085 b and 0.091 c
chloroquine 0.002 b,c
podophyllotoxin 0.005
b and
0.007 c
1-O-acetylcaranine (6) 1.97 35.9 >100 3.21 14.2
3-O-acetylhamayne (24) 1.51 8.3 17.9 1.14 1.72
buphanamine (16) 28.2 62.9 >100 25.9 >100
crude extract 4.67 34.9 >100 1.17 34.3
a all values expressed as µg mL−1; b reference value to 1-O-acetylcaranine; c reference value to buphanamine,
3-O-acetylhamayne and crude extract.
3. Materials and Methods
3.1. Plant Material
Bulbs of Amaryllis belladonna L. were collected in Canela (Rio Grande do Sul, Brazil) in August
2014. The first sample was authenticated by Dr. Julie H. A. Dutilh, University of Campinas (Unicamp,
Campinas, Brazil). A specimen voucher (179860) has been deposited in the Herbarium of the
Universidade Federal do Rio Grande do Sul (UFRGS, Porto Alegre, Brazil).
3.2. Equipment
About 2 mg of each alkaloid extract was dissolved in 1 mL of MeOH and/or CHCl3 and injected
directly into the GC–MS apparatus (Agilent Technologies 6890N coupled with MSD5975 inert XL)
operating in the electron ionization (EI) mode at 70 eV. A Sapiens-X5 MS column (30 m × 0.25 mm
i.d., film thickness 0.25 µm) was used. The temperature gradient performed was as follows: 12 min
at 100 ◦C, 100–180 ◦C at 15 ◦C/min, 180–300 ◦C at 5 ◦C/min and 10 min hold at 300 ◦C. The injector
and detector temperatures were 250 and 280 ◦C, respectively, and the flow-rate of carrier gas (He) was
1 mL/min. A split ratio of 1:5 was applied and the injection volume was 1 µL.
1H- and 13C-NMR, COSY, NOESY, HMQC and HMBC spectra were recorded on a Varian VNMRS
500 MHz using CDCl3 as the solvent and TMS as the internal standard. Chemical shifts were reported
in units of δ (ppm) and coupling constants (J) expressed in Hz. CD, UV and IR spectra were recorded
on Jasco-J-810, Dinko UV2310 and Thermo Scientific Nicolet iN10 MX spectrophotometers, respectively.
High-resolution electrospray ionization mass spectrometry (HR–ESI–MS) spectra were obtained on an
LC/MSD-TOF (2006) mass spectrometer (Agilent Technologies). Silica gel SDS chromagel 60 A CC
(6–35 µm) was used for vacuum liquid chromatography (VLC), and silica gel 60 F254 Macherey-Nagel
for analytics and prep. Spots on chromatograms were detected under UV light (254 nm) and by
Dragendorff’s reagent stain.
3.3. Extraction
Fresh bulbs (2.5 kg) of A. belladonna were dried at 40 ◦C for seven days. After this, the dried
material (950 g) was macerated with MeOH (4 × 2 L) at room temperature for 48 h, the combined
macerate was filtered and the solvent evaporated to dryness under reduced pressure. The bulb crude
extract (105 g) was then acidified to pH 3 with diluted H2SO4 (5% v/v) and the neutral material
removed with Et2O (10 × 200 mL). The aqueous solution was basified up to pH 9–10 with NH4OH
(25% v/v) and extracted with n-Hexane (12 × 200 mL) to give the n-hexane extract (0.47 g), which was
followed by extraction with EtOAc (15 × 200 mL) to provide the EtOAc extract (4.07 g).
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The extracts were subjected to a combination of chromatographic techniques, including vacuum
liquid chromatography (VLC) [25] and semi-preparative thin-layer chromatography (TLC). The general
VLC procedure consisted of the use of a silica gel 60 A (6–35 µm) column with a height of 4 cm and a
variable diameter according to the amount of sample (2.5 cm for 400–1000 mg; 1.5 cm for 150–400 mg).
Alkaloids were eluted with n-hexane containing increasing EtOAc concentrations, followed by neat
EtOAc, which was gradually enriched with MeOH (reaching a maximum concentration of 20%
v/v). Fractions of 10–15 mL were collected, monitored by TLC (UV 254 nm, Dragendorff’s reagent)
and combined according to their profiles. For semi-preparative TLC, silica gel 60F254 was used
(20 cm × 20 cm × 0.25 mm) together with different solvent mixtures depending on each particular
sample (EtOAc:MeOH, 9:1 v/v, or EtOAc:MeOH, 8:2 v/v), always in an environment saturated with
ammonia. The alkaloids were each identified by GC–MS and the three known alkaloids were isolated
and structurally elucidated by NMR as 1-O-acetylcaranine (362.9 mg), 3-O-acetylhamayne (2.2 mg)
and buphanamine (17.2 mg).
3.4. Characterization of Compounds
1-O-Acetylcaranine (6). [α]22D −161.84 (c 0.0009, CHCl3); UV (MeOH) λmax (log ε): 290.5 (3.77), 235.5
(3.76) nm; IR (CHCl3) νmax 2888, 1726, 1505, 1487, 1487, 1450, 1376, 1238, 1033, 934, 847 cm−1; 1H-NMR
(CDCl3, 500 MHz) and 13C-NMR (CDCl3, 125 MHz) see Table 2; ESI–MS data shown in Table 1;
HR–ESI–MS of [M + H]+ m/z 314.1394 (calcd. for C18H20NO4, 314.1387).
Buphanamine (16). [α]22D −169.03 (c 0.0009, CHCl3); UV (MeOH) λmax (log ε): 285.0 (3.17), 207.0 (4.14)
nm; CD (MeOH, 20 ◦C) ∆ε250 +1792, ∆ε268 −247, ∆ε288 +293; IR νmax 3334, 2923, 1619, 1478, 1240, 1080,
1044, 753 cm−1; 1H-NMR (CDCl3, 500 MHz) and 13C-NMR, 125 MHz) see Table 3; ESI–MS data shown
in Table 1; HR–ESI–MS of [M + H]+ m/z 302.1385 (calcd. for C17H20NO4, 302.1387).
Supplementary Materials: Supplementary Materials are available online.
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